Medifast (MED) | Stock Overview & Key Data
Medifast Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $336.99 on May 24, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Join Our United States Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Dec 31, 2025
Annual Income Flow
2025
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Medifast
MED
|
121.13M Micro-cap | -6.69% | 15.43% | 14.57% | 12.98% | 17.98% | -10.95% | -85.01% | -95.99% | -61.95% | -51.02% | -36.36% |
|
Rollins
ROL
|
27.47B Large-cap | -5.91% | -14.13% | -19.83% | -22.94% | -21.20% | -16.86% | 17.15% | 43.42% | 273.33% | 736.56% | 1,730.77% |
|
Service
SCI
|
11.76B Large-cap | -8.49% | -11.25% | -14.88% | -8.17% | -9.57% | -3.60% | 16.32% | 41.98% | 175.12% | 575.56% | 835.20% |
| 92.67M Micro-cap | 0.94% | 58.20% | -25.18% | -33.41% | -45.10% | 6,292.31% | 131.15% | -58.43% | 9.85% | -78.19% | -60.76% | |
|
Regis
RGS
|
67.69M Micro-cap | -5.83% | 3.23% | 23.32% | -5.15% | 2.66% | 29.78% | 28.36% | -84.83% | -88.92% | 97.62% | -19.75% |
| 9.25M Micro-cap | -0.83% | -2.46% | -9.16% | -44.13% | -39.29% | -26.45% | -81.00% | -89.30% | -92.08% | -92.08% | -92.08% |
Ownership & Short Interest
Calculate Your Medifast Investment Returns
Long-Term Investment Performance Analysis
Medifast stock price in May 2016 was $32.93, A $1,000.00 lump sum investment in Medifast made 10 years ago would be worth approximately $372.61 today, representing a negative return of -62.74%. This translates to an annualized return (CAGR) of -9.39%.
10 Years Investment Scenario (May 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is MED's 52-week high and low?
- In the last 52 weeks, Medifast reached a high of $15.46 (on July 10, 2025) and a low of $9.22 (on March 13, 2026).
- What is the market cap and P/E ratio for MED?
- Curious about Medifast's size and valuation? Its market capitalization stands at 121.13M. When it comes to valuation, the P/E ratio (trailing twelve months) is 531.50, and the forward P/E (looking ahead) is -4.00.
- Does MED pay dividends? If so, what's the yield?
- As for dividends, Medifast isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Medifast's main competitors or similar companies to consider before investing?
When looking at Medifast, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Rollins
ROL27.47B Consumer Cyclical Personal Services -16.86% 17.15% Service
SCI11.76B Consumer Cyclical Personal Services -3.60% 16.32% WW International
WW92.67M Consumer Cyclical Personal Services 6,292.31% 131.15% Regis
RGS67.69M Consumer Cyclical Personal Services 29.78% 28.36% Medirom Healthcare
MRM9.25M Consumer Cyclical Personal Services -26.45% -81.00% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Medifast Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Medifast's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is -9.13%, the Debt to Equity ratio from the most recent quarter is 5.38, and its Gross Profit Margin stands at 69.43%.
- What is the recent revenue and earnings growth for MED?
- Looking at Medifast's growth, its revenue over the trailing twelve months (TTM) was $386M. Compared to the same quarter last year (YoY), quarterly revenue grew by -36.90%, and quarterly earnings saw a YoY growth of -36.90%.
- How much of MED stock is held by insiders and institutions?
- Wondering who owns Medifast stock? Company insiders (like executives and directors) hold about 3.86% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 78.14%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.